Zealand Pharma

This early-stage study is testing how the body processes different concentrations of petrelintide, an experimental drug being developed for weight management. Researchers will give a single injection to 48 adults with overweight or obesity and track how the drug moves through the…

This is a two-year extension study for adults with short bowel syndrome who completed a previous trial. It aims to see if weekly injections of glepaglutide remain safe and effective over the long term. The study will monitor side effects and whether the treatment continues to hel…

This study is following children with congenital hyperinsulinism (CHI) to see how safe and effective the drug dasiglucagon is over a long period. CHI causes dangerously low blood sugar. The drug is given as a continuous infusion under the skin. The main goal is to monitor side ef…

This study is testing the long-term safety and effectiveness of a drug called glepaglutide for people with short bowel syndrome. The trial involves 145 patients who previously participated in related studies, following them to see if the treatment continues to help reduce their n…

This study follows patients with short bowel syndrome for two years to see if continuing treatment with glepaglutide remains safe and effective. It includes 35 adults who were already receiving this medication in previous trials. The main goal is to monitor side effects and see i…

This study is testing a new weekly injection called petrelintide to see if it helps people with obesity and type 2 diabetes lose weight and better control their blood sugar. About 221 participants will receive either the drug or a placebo (dummy injection) for comparison. The mai…